Medical Ikkou Co., Ltd. acquired Tsurukame Chozai Pharmacy, Ltd from Takako Muraoka and Michip Muraoka.
August 31, 2016
Share
Medical Ikkou Co., Ltd. (JASDAQ:3353) agreed to acquire Tsurukame Chozai Pharmacy, Ltd from Takako Muraoka and Michip Muraoka on July 20, 2016. Medical Ikkou Co., Ltd. (JASDAQ:3353) entered into a contract to acquire Tsurukame Chozai Pharmacy, Ltd from Takako Muraoka and Michip Muraoka on August 1, 2016. Medical Ikkou will acquire 300 shares of Tsurukame Chozai Pharmacy in the deal. Takako Muraoka and Michip Muraoka will each sell 50% stake in Tsurukame Chozai Pharmacy. Tsurukame Chozai Pharmacy had total assets of ¥84.73 million, net assets of ¥19.58 million, revenues of ¥222.44 million, EBIT of ¥2.49 million and net income of ¥2.6 million for the year ended September 30, 2015. Deal was resolved on July 20, 2016.
Medical Ikkou Co., Ltd. (JASDAQ:3353) completed the acquisition of Tsurukame Chozai Pharmacy, Ltd from Takako Muraoka and Michip Muraoka on August 1, 2016.
Medical Ikkou Group Co.,Ltd. is a Japan-based company mainly engaged in the operation of dispensing pharmacies that fill prescriptions for general patients based on the medical prescriptions issued by medical institutions. The Company operates in four business segments. The Dispensing Pharmacy segment is specialized in the sale of medical drugs based on medical prescriptions. The Healthcare segment is engaged in the operation of nursing care facilities, the leasing of medical facilities and others, as well as the medical care and nursing care related businesses. The Medicine Wholesale segment is engaged in the sale of pharmaceutical products to medical institutions and others. The Real Estate segment is engaged in the leasing of real estate properties.
MEDICAL IKKOU GROUP CO.,LTD. 